https://www.moneycontrol.com/news/business/markets/sequent-scientific-zooms-14-on-terminating-tineta-pharma-acquisition-10220641.html
0
0
3/9/23 at 5:05am
Organization
Moneycontrol
Author
Vaibhavi Ranjan
The stock has corrected over 79.4 percent from its lifetime highs tested in July 2021.
Create an account
or login to join the discussion